Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Soligenix, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Soligenix is a late-stage biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company has active programs in fibrosis and inflammation, vaccines, and oncology. Soligenix is advancing multiple clinical-stage product candidates including treatments for gastrointestinal diseases and biodefense countermeasures.